Literature DB >> 21258859

Coffee consumption and reduced risk of hepatocellular carcinoma: findings from the Singapore Chinese Health Study.

Shane Johnson1, Woon-Puay Koh, Renwei Wang, Sugantha Govindarajan, Mimi C Yu, Jian-Min Yuan.   

Abstract

BACKGROUND: Coffee consumption has been associated with reduced markers of hepatic cell damage, reduced risk of chronic liver disease, and cirrhosis across a variety of populations. Data on the association between coffee consumption and risk of hepatocellular carcinoma (HCC), especially in high-risk populations, are sparse.
METHODS: This study examines the relationship between coffee and caffeine consumption, and the risk of developing HCC within the Singapore Chinese Health Study, a prospective cohort of 63,257 middle-aged and older Chinese men and women, a relatively high-risk population for HCC. Baseline data on coffee consumption and other dietary and lifestyle factors were collected through in-person interviews at enrollment between 1993 and 1998.
RESULTS: As of 31 December 2006, 362 cohort participants had developed HCC. High levels of coffee or caffeine consumption were associated with reduced risk of HCC (p for trend < 0.05). Compared with non-drinkers of coffee, individuals who consumed three or more cups of coffee per day experienced a statistically significant 44% reduction in risk of HCC (hazard ratio 0.56, 95% confidence interval, 0.31-1.00, p = .049) after adjustment for potential confounders and tea consumption.
CONCLUSION: These data suggest that coffee consumption may reduce the risk of developing HCC in Chinese in Singapore.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21258859      PMCID: PMC3400401          DOI: 10.1007/s10552-010-9725-0

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  37 in total

1.  Singapore Chinese Health Study: development, validation, and calibration of the quantitative food frequency questionnaire.

Authors:  J H Hankin; D O Stram; K Arakawa; S Park; S H Low; H P Lee; M C Yu
Journal:  Nutr Cancer       Date:  2001       Impact factor: 2.900

Review 2.  Global cancer statistics in the year 2000.

Authors:  D M Parkin
Journal:  Lancet Oncol       Date:  2001-09       Impact factor: 41.316

3.  Anti-human immunodeficiency virus type 1 gene therapy in human central nervous system-based cells: an initial approach against a potential viral reservoir.

Authors:  M Mukhtar; H Duke; M BouHamdan; R J Pomerantz
Journal:  Hum Gene Ther       Date:  2000-01-20       Impact factor: 5.695

4.  A prospective study of green tea consumption and cancer incidence, Hiroshima and Nagasaki (Japan).

Authors:  J Nagano; S Kono; D L Preston; K Mabuchi
Journal:  Cancer Causes Control       Date:  2001-08       Impact factor: 2.506

5.  Protective effects of coffee diterpenes against aflatoxin B1-induced genotoxicity: mechanisms in rat and human cells.

Authors:  C Cavin; K Mace; E A Offord; B Schilter
Journal:  Food Chem Toxicol       Date:  2001-06       Impact factor: 6.023

6.  Hepatocarcinogenesis inhibition by caffeine in ACI rats treated with 2-acetylaminofluorene.

Authors:  S Hosaka; S Kawa; Y Aoki; E Tanaka; K Yoshizawa; Y Karasawa; N Hosaka; K Kiyosawa
Journal:  Food Chem Toxicol       Date:  2001-06       Impact factor: 6.023

7.  Green tea consumption and the risk of liver cancer in Japan: the Ohsaki Cohort study.

Authors:  Akane Ui; Shinichi Kuriyama; Masako Kakizaki; Toshimasa Sone; Naoki Nakaya; Kaori Ohmori-Matsuda; Atsushi Hozawa; Yoshikazu Nishino; Ichiro Tsuji
Journal:  Cancer Causes Control       Date:  2009-09-19       Impact factor: 2.506

8.  Antioxidant and prooxidant properties of caffeine, theobromine and xanthine.

Authors:  Sonish Azam; Naghma Hadi; Nizam Uddin Khan; Sheikh Mumtaz Hadi
Journal:  Med Sci Monit       Date:  2003-09

Review 9.  Cafestol and kahweol, two coffee specific diterpenes with anticarcinogenic activity.

Authors:  C Cavin; D Holzhaeuser; G Scharf; A Constable; W W Huber; B Schilter
Journal:  Food Chem Toxicol       Date:  2002-08       Impact factor: 6.023

10.  Does coffee protect against hepatocellular carcinoma?

Authors:  S Gallus; M Bertuzzi; A Tavani; C Bosetti; E Negri; C La Vecchia; P Lagiou; D Trichopoulos
Journal:  Br J Cancer       Date:  2002-10-21       Impact factor: 7.640

View more
  27 in total

Review 1.  Management of NAFLD: a stage-based approach.

Authors:  Mary E Rinella; Arun J Sanyal
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-02-24       Impact factor: 46.802

Review 2.  Lifestyle and Dietary Interventions in the Management of Nonalcoholic Fatty Liver Disease.

Authors:  William N Hannah; Stephen A Harrison
Journal:  Dig Dis Sci       Date:  2016-05       Impact factor: 3.199

Review 3.  Tea and cancer prevention: epidemiological studies.

Authors:  Jian-Min Yuan; Canlan Sun; Lesley M Butler
Journal:  Pharmacol Res       Date:  2011-03-23       Impact factor: 7.658

4.  Coffee and liver - long way to go.

Authors:  Ajay K Duseja
Journal:  J Clin Exp Hepatol       Date:  2012-09-21

5.  Chemoprevention against hepatocellular carcinoma.

Authors:  Jun-Ichi Okano; Yuki Fujise; Ryo Abe; Ryu Imamoto; Yoshikazu Murawaki
Journal:  Clin J Gastroenterol       Date:  2011-06-04

Review 6.  Coffee Drinking and Reduced Risk of Liver Cancer: Update on Epidemiological Findings and Potential Mechanisms.

Authors:  Manami Inoue; Shoichiro Tsugane
Journal:  Curr Nutr Rep       Date:  2019-09

7.  Association between Dietary Tomato Intake and the Risk of Hepatocellular Carcinoma: The Singapore Chinese Health Study.

Authors:  Claire E Thomas; Hung N Luu; Renwei Wang; Jennifer Adams-Haduch; Aizhen Jin; Woon-Puay Koh; Jian-Min Yuan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-04-13       Impact factor: 4.254

8.  Caffeine and the analog CGS 15943 inhibit cancer cell growth by targeting the phosphoinositide 3-kinase/Akt pathway.

Authors:  Charlotte E Edling; Federico Selvaggi; Ragheda Ghonaim; Tania Maffucci; Marco Falasca
Journal:  Cancer Biol Ther       Date:  2014-02-12       Impact factor: 4.742

Review 9.  Coffee Consumption and Cancer Risk: An Assessment of the Health Implications Based on Recent Knowledge.

Authors:  Ernest K J Pauwels; Duccio Volterrani
Journal:  Med Princ Pract       Date:  2021-03-24       Impact factor: 1.927

10.  Coffee, tea and decaffeinated coffee in relation to hepatocellular carcinoma in a European population: multicentre, prospective cohort study.

Authors:  Christina Bamia; Pagona Lagiou; Mazda Jenab; Antonia Trichopoulou; Veronika Fedirko; Krasimira Aleksandrova; Tobias Pischon; Kim Overvad; Anja Olsen; Anne Tjønneland; Marie-Christine Boutron-Ruault; Guy Fagherazzi; Antoine Racine; Tilman Kuhn; Heiner Boeing; Anna Floegel; Vasiliki Benetou; Domenico Palli; Sara Grioni; Salvatore Panico; Rosario Tumino; Paolo Vineis; H B Bueno-de-Mesquita; Vincent K Dik; Nirmala Bhoo-Pathy; Cuno S P M Uiterwaal; Elisabete Weiderpass; Eiliv Lund; J Ramón Quirós; Raul Zamora-Ros; Esther Molina-Montes; Maria-Dolores Chirlaque; Eva Ardanaz; Miren Dorronsoro; Björn Lindkvist; Peter Wallström; Lena Maria Nilsson; Malin Sund; Kay-Tee Khaw; Nick Wareham; Kathryn E Bradbury; Ruth C Travis; Pietro Ferrari; Talita Duarte-Salles; Magdalena Stepien; Marc Gunter; Neil Murphy; Elio Riboli; Dimitrios Trichopoulos
Journal:  Int J Cancer       Date:  2014-09-24       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.